Literature DB >> 3323305

Progress in the treatment of portal-systemic encephalopathy (PSE).

K P Maier1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3323305     DOI： 10.1016/s0168-8278(87)80042-9

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  3 in total

Review 1.  Traditional management of liver disorders.

Authors:  M Messner; P Brissot
Journal:  Drugs       Date:  1990       Impact factor: 9.546

2.  Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy. Results of a double-blind crossover trial.

Authors:  O Riggio; F Ariosto; M Merli; M Caschera; A Zullo; G Balducci; V Ziparo; G Pedretti; F Fiaccadori; E Bottari
Journal:  Dig Dis Sci       Date:  1991-09       Impact factor: 3.199

Review 3.  Rifaximin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential in conditions mediated by gastrointestinal bacteria.

Authors:  J C Gillis; R N Brogden
Journal:  Drugs       Date:  1995-03       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.